UPDATE: Morgan Stanley Downgrades ADC Therapeutics (ADCT) to Equalweight
Tweet Send to a Friend
(Updated - September 9, 2022 5:31 AM EDT)
Morgan Stanley analyst Matthew Harrison downgraded ADC Therapeutics (NYSE: ADCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison downgraded ADC Therapeutics (NYSE: ADCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
